Cupid Limited (CUPID) Gross Profit 2023–2026

Name: Cupid Limited (CUPID) gross profit history 2023-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Cupid Limited annual gross profit for fiscal 2026 was ₹2.0 billion, an increase of 79.0% from ₹1.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

CUPID Annual Gross Profit

Gross Profit (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Gross Profit	₹2.0B	₹1.1B	₹1.1B	₹905M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CUPID Quarterly Gross Profit

Gross Profit (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Gross Profit	₹899M	₹653M	₹584M	₹502M	₹357M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Gross Profit at Comparable Companies

COLPAL Gross Profit — Colgate-Palmolive (India) Limited
4912 Gross Profit — Lion Corporation
4967 Gross Profit — Kobayashi Pharmaceutical Co., Ltd.
8283 Gross Profit — Paltac Corporation
4922 Gross Profit — KOSE Holdings Corporation
4927 Gross Profit — Pola Orbis Holdings Inc.

More CUPID metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow

All CUPID financial statements → Interactive CUPID charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.